Boomfish Wealth Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Boomfish Wealth Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.89M	Buy	6,463 +53	+0.8%	+$24.7K	1.54%	23
2025 Q4	$2.91M	Sell	6,410 -237	-4%	-$102K	1.55%	25
2025 Q3	$2.6M	Buy	6,647 +1,404	+27%	+$587K	1.4%	32
2025 Q2	$2.33M	Buy	5,243 +192	+4%	+$88.5K	1.35%	34
2025 Q1	$2.45M	Sell	5,051 -41	-0.8%	-$19.1K	1.59%	21
2024 Q4	$2.05M	Buy	5,092 +268	+6%	+$124K	1.24%	36
2024 Q3	$2.24M	Sell	4,824 -151	-3%	-$72.5K	1.38%	35
2024 Q2	$2.33M	Sell	4,975 -107	-2%	-$46.4K	1.51%	27
2024 Q1	$2.12M	Sell	5,082 -350	-6%	-$148K	1.43%	36
2023 Q4	$2.21M	Buy	+5,432	New	+$2.01M	1.6%	25

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boomfish Wealth Group's VRTX Position: Q1 2026 in Review

Boomfish Wealth Group increased its Vertex Pharmaceuticals (VRTX) stake by 0.83% in Q1 2026, buying an estimated $24.7K and bringing the position to 6,463 shares worth $2.89M. The position accounts for 1.54% of the portfolio, ranked #23.

Boomfish Wealth Group first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.91M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Boomfish Wealth Group held 6,463 shares of Vertex Pharmaceuticals worth $2.89M as of Q1 2026.
Boomfish Wealth Group bought 53 Vertex Pharmaceuticals shares in Q1 2026, an estimated $24.7K.
Vertex Pharmaceuticals made up 1.54% of Boomfish Wealth Group's portfolio in Q1 2026, its #23 holding.
Boomfish Wealth Group first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
Boomfish Wealth Group's Vertex Pharmaceuticals position peaked at $2.91M in Q4 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Boomfish Wealth Group's 13F filing for Q1 2026, filed 22 Apr 2026.